Avarieux
back to explore
cbdMD Inc logo

YCBD

cbdMD Inc
NYSE MKT LLC· Pharmaceuticals· US· IPO 2017-11-17
$0.48
-0.02 (-3.76%)
last quote
Want the full multi-source brief on YCBD?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
open in agent
Today
Open
$0.48
High
$0.49
Low
$0.45
Previous close
$0.50
Fundamentals
Market cap
$5.60M
P/E (TTM)
—
P/S (TTM)
0.27x
P/B
1.49x
Gross margin
57.68%
Operating margin
-13.87%
Net margin
-13.80%
Rev growth (YoY)
10.01%
EPS growth (YoY)
—
ROE
-34.25%
52W high
$2.56
52W low
$0.47
Beta
2.31x
Industry peers
by market cap
HEPA-7.04%CBSC+0.00%PCSA-2.38%SNES-1.89%PULM-7.48%CVKD-3.76%EMMA+9.23%JUNS-4.96%
Recent SEC filings
CIK 1644903filing-language history →
8-K2026-09-02reports 2026-09-01
583 KB
10-Q2026-08-13reports 2026-06-30
6,357 KB
8-K2026-05-20
252 KB
10-Q2026-05-14reports 2026-03-31
5,987 KB
42026-04-16reports 2026-04-14
8 KB
42026-04-16reports 2026-04-14
5 KB
Recent news
2026-08-28 → 2026-09-04
Yahoo · 1d
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness
cbdMD, Inc. (NYSE American: YCBD), a leading consumer wellness company, today announced that it has entered into a definitive asset purchase agreement to acquire operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and Alvita Tea. The acquisition is being conducted through an assignment for the benefit of creditors (ABC) proceeding and is subject to court approval and
SEC EDGAR Yahoo Finance TradingView Company website
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial